ZSRI 📈 BNP Paribas Easy MSCI - Overview
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU1753045415 • Europe Large-Cap Blend Equity
ZSRI: Stocks, Bonds, Equities, Investments
‣ Company URL: http://www.bnpparibas-am.com ‣ Domicile: Luxembourg ‣ Index Name: Morningstar DM Eur TME NR EUR
Additional Sources for ZSRI ETF
ZSRI ETF Overview
| Market Cap in USD | 1,521m |
| Category | Europe Large-Cap Blend Equity |
| TER | 0.25% |
| IPO / Inception | 2022-01-01 |
ZSRI ETF Ratings
| Growth 5y | 55.6% |
| Fundamental | - |
| Dividend | 43.9% |
| Rel. Strength Industry | 126 |
| Analysts | - |
| Fair Price Momentum | 26.72 EUR |
| Fair Price DCF | - |
ZSRI Dividends
| Dividend Yield 12m | 3.01% |
| Yield on Cost 5y | 4.22% |
| Annual Growth 5y | % |
| Payout Consistency | 100.0% |
ZSRI Growth Ratios
| Growth Correlation 3m | -60.1% |
| Growth Correlation 12m | 76.9% |
| Growth Correlation 5y | 81.4% |
| CAGR 5y | 6.90% |
| CAGR/Mean DD 5y | 0.94 |
| Sharpe Ratio 12m | 0.41 |
| Alpha | -11.97 |
| Beta | 0.68 |
| Volatility | 13.29% |
| Current Volume | 31.2k |
| Average Volume 20d | 5k |
What is the price of ZSRI stocks?
As of December 27, 2024, the stock is trading at EUR 28.27 with a total of 31,224 shares traded.
Over the past week, the price has changed by +0.07%, over one month by -0.51%, over three months by -4.80% and over the past year by +6.82%.
As of December 27, 2024, the stock is trading at EUR 28.27 with a total of 31,224 shares traded.
Over the past week, the price has changed by +0.07%, over one month by -0.51%, over three months by -4.80% and over the past year by +6.82%.
Is BNP Paribas Easy MSCI a good stock to buy?
Partly, yes. Based on ValueRay Analyses, BNP Paribas Easy MSCI (XETRA:ZSRI) is currently (December 2024) ok to buy, but has to be watched. It has a Growth Technical Rating of 55.64 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ZSRI as of December 2024 is 26.72. This means that ZSRI is currently overvalued and has a potential downside of -5.48%.
Partly, yes. Based on ValueRay Analyses, BNP Paribas Easy MSCI (XETRA:ZSRI) is currently (December 2024) ok to buy, but has to be watched. It has a Growth Technical Rating of 55.64 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ZSRI as of December 2024 is 26.72. This means that ZSRI is currently overvalued and has a potential downside of -5.48%.
Is ZSRI a buy, sell or hold?
BNP Paribas Easy MSCI has no consensus analysts rating.
BNP Paribas Easy MSCI has no consensus analysts rating.
What are the forecast for ZSRI stock price target?
According to ValueRays Forecast Model, ZSRI BNP Paribas Easy MSCI will be worth about 29.4 in December 2025. The stock is currently trading at 28.27. This means that the stock has a potential upside of +4.07%.
According to ValueRays Forecast Model, ZSRI BNP Paribas Easy MSCI will be worth about 29.4 in December 2025. The stock is currently trading at 28.27. This means that the stock has a potential upside of +4.07%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 29.4 | 4.1% |